Chronic Diffuse Lung Diseases

Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series

Volumn , Issue , 2011, Pages 213-276

  Fukuoka, Junya ^a   Leslie, Kevin O ^b  

^a TOYAMA UNIVERSITY HOSPITAL   (Japan)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85159396069     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5770-3.00007-9     Document Type: Chapter

References (457)

1. K. Leslie and T. Colby (1999) Classification and pathology of diffuse interstitial lung disease. Semin Clin Immunol 1 7-15.
2. K.O. Leslie (2009) My approach to interstitial lung disease using clinical, radiological and histopathologic patterns. J Clin Pathol 62(5), 387-401.
3. K.O. Leslie, J.F. Gruden, J.M. Parish and M.B. Scholand (2007) Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med 131(3), 407-423.
4. B. Elicker, C.A. Pereira, R. Webb and K.O. Leslie (2008) High-resolution computed tomography patterns of diffuse interstitial lung disease with clinical and pathological correlation. J Bras Pneumol 34(9), 715-744.
5. American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161(2 Pt 1), 646-664.
6. American Thoracic Society/European Respiratory Society (2002) International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am Rev Respir Crit Care Med 165(2), 227-304.
7. A.L. Liebow and C.B. Carrington (1969) The interstitial pneumonias. M. Simon, E.J. Potchen, M. LeMay,(Eds) Frontiers of Pulmonary Radiology: Pathophysiologic, Roentgenographic and Radioisotopic Considerations New York: Grune & Stratton 102-141.
8. A.L. Katzenstein (1993) Idiopathic interstitial pneumonia: classification and diagnosis. Monogr Pathol 36 1-31.
9. A.L. Katzenstein and J.L. Myers (2000) Nonspecific interstitial pneumonia and the other idiopathic interstitial pneumonias: classification and diagnostic criteria. Am J Surg Pathol 24(1), 1-3.
10. R. Crystal, J.D. Fulmer, W.C. Roberts, et al. (1976) Idiopathic pulmonary fibrosis: clinical histologic, radiographic, physiologic, scintigraphic, cytologic and biochemical aspects. Ann Intern Med 85 769-788.
11. C.B. Carrington, E.A. Gaensler, R.E. Coutu, et al. (1976) Usual and desquamative interstitial pneumonia. Chest 69(suppl 2), 261-263.
12. M.C. Aubry, J.L. Wright and J.L. Myers (2000) The pathology of smoking-related lung diseases. Clin Chest Med 21(1), 11-35. vii
13. N. Ohori, F.C. Sciurba, G.R. Owens, et al. (1989) Giant-cell interstitial pneumonia and hard-metal pneumoconiosis. A clinicopathologic study of four cases and review of the literature. Am J Surg Pathol 13(7), 581-587.
14. C.C. Lewis, J.Y. Yang, X. Huang, et al. (2008) Disease-specific gene expression profiling in multiple models of lung disease. Am J Respir Crit Care Med 177(4), 376-387.
15. A. Katzenstein, J. Myers and M. Mazur (1986) Acute interstitial pneumonia: a clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 10 256-267.
16. A.L. Katzenstein and R.F. Fiorelli (1994) Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 18(2), 136-147.
17. G.R. Epler, T.V. Colby, T.C. McLoud, et al. (1985) Bronchiolitis obliterans organizing pneumonia. N Engl J Med 312(3), 152-158.
18. K.O. Leslie (2005) Pathology of the idiopathic interstitial pneumonias. Exp Lung Res 31(suppl 1), 23-40.
19. J. Gough (1965) Differential diagnosis in the pathology of asbestosis. Ann N Y Acad Sci 132 368-372.
20. J. Gadek, G. Hunninghake, C. Schoenberger, et al. (1981) Pulmonary asbestosis and idiopathic pulmonary fibrosis: pathogenetic parallels. Chest 80(suppl 1), 63-64.
21. S. Yamamoto (1997) Histopathological features of pulmonary asbestosis with particular emphasis on the comparison with those of usual interstitial pneumonia. Osaka City Med J 43(2), 225-242.
22. K. Leslie, T.E. King Jr and R. Low (1991) Smooth muscle actin is expressed by air space fibroblast-like cells in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Chest 99(suppl 3), 47S-48S.
23. B.D. Adler, S.P. Padley, N.L. Müller, et al. (1992) Chronic hypersensitivity pneumonitis: high resolution CT and radiographic features in 16 patients. Radiology 185 91-95.
24. D.A. Lynch, J.D. Newell, P.M. Logan, et al. (1995) Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol 165(4), 807-811.
25. G. Hunninghake and A. Fauci (1979) Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 119 471-503.
26. T.V. Colby (1990) Pathology of the lung in collagen vascular diseases. G. Cannon, G. Zimmerman,(Eds) The Lung Rheumatic Diseases New York: Marcel Dekker 145-178.
27. K.O. Leslie, S. Trahan and J. Gruden (2007) Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med 28(4), 369-378.
28. C. Lamblin, C. Bergoin, T. Saelens and B. Wallaert (2001) Interstitial lung diseases in collagen vascular diseases. Eur Respir J Suppl 32 69s-80s.
29. S.E. Rossi, J.J. Erasmus, H.P. McAdams, et al. (2000) Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 20(5), 1245-1259.
30. G. Raghu, D. Weycker, J. Edelsberg, et al. (2006) Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174(7), 810-816.
31. D.B. Coultas (1993) Epidemiology of idiopathic pulmonary fibrosis. Semin Respir Med 14 181-196.
32. M. Guerry-Force, N.L. Müller, J.L. Wright, et al. (1987) A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia and small airways disease. Am Rev Respir Dis 135 705-712.
33. C. Staples, N.L. Müller, S. Vedal, et al. (1987) Usual interstitial pneumonia: correlations of CT with clinical, functional and radiologic findings. Radiology 162 377-381.
34. G. Epler, T.C. McLoud, E.A. Gaensler, et al. (1978) Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 298 934-939.
35. M. Akira, M. Sakatani and E. Ueda (1993) Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT. Radiology 189(3), 687-691.
36. K. Nishimura and H. Itoh (1992) High-resolution computed tomographic features of bronchiolitis obliterans organizing pneumonia. Chest 102 26S-31S.
37. D.A. Lynch (1996) Ground glass attenuation on CT in patients with idiopathic pulmonary fibrosis. Chest 110(2), 312-313.
38. E.A. Kazerooni, F.J. Martinez, A. Flint, et al. (1997) Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 169(4), 977-983.
39. G.W. Hunninghake, M.B. Zimmerman, D.A. Schwartz, et al. (2001) Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 164(2), 193-196.
40. A. Katzenstein, J.L. Myers, W.D. Prophet, et al. (1986) Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study. Am J Surg Pathol 10 373-376.
41. J.S. Lee, G. Gong, K.S. Song, et al. (1998) Usual interstitial pneumonia: relationship between disease activity and the progression of honeycombing at thin-section computed tomography. J Thorac Imaging 13(3), 199-203.
42. J.L. Myers (1998) NSIP, UIP, and the ABCs of idiopathic interstitial pneumonias. Eur Respir J 12(5), 1003-1004.
43. T. Nagao, S. Nagai, M. Kitaichi, et al. (2001) Usual interstitial pneumonia: idiopathic pulmonary fibrosis versus collagen vascular diseases. Respiration 68(2), 151-159.
44. C.D. Cool, S.D. Groshong, P.R. Rai, et al. (2006) Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med 174(6), 654-658.
45. K.R. Flaherty, T.V. Colby, W.D. Travis, et al. (2003) Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 167(10), 1410-1415.
46. Y. Kondoh, H. Taniguchi, Y. Kawabata, et al. (1993) Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 103(6), 1808-1812.
47. H.R. Collard, B.B. Moore, K.R. Flaherty, et al. (2007) Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176(7), 636-643.
48. R.J. Panos, R.L. Mortenson, S.A. Niccoli and T.E. King Jr (1990) Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 88(4), 396-404.
49. D.S. Kim, J.H. Park, B.K. Park, et al. (2006) Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 27(1), 143-150.
50. A.L. Katzenstein, D.A. Zisman, L.A. Litzky, et al. (2002) Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol 26(12), 1567-1577.
51. K.R. Flaherty, W.D. Travis, T.V. Colby, et al. (2001) Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 164(9), 1722-1727.
52. I. Noth and F.J. Martinez (2007) Recent advances in idiopathic pulmonary fibrosis. Chest 132(2), 637-650.
53. J.A. Bjoraker, J.H. Ryu, M.K. Edwin, et al. (1998) Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157(1), 199-203.
54. G. Raghu, K.K. Brown, U. Costabel, et al. (2008) Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med 178(9), 948-955.
55. K. Ask, G.E. Martin, M. Kolb and J. Gauldie (2006) Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls. Proc Am Thorac Soc 3(4), 389-393.
56. J.C. Grutters and R.M. du Bois (2005) Genetics of fibrosing lung diseases. Eur Respir J 25(5), 915-927.
57. Y. Wang, P.J. Kuan, C. Xing, et al. (2009) Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 84(1), 52-59.
58. M.P. Steele, M.C. Speer, J.E. Loyd, et al. (2005) Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 172(9), 1146-1152.
59. M.Y. Armanios, J.J. Chen, J.D. Cogan, et al. (2007) Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 356(13), 1317-1326.
60. M. Kitaichi (1990) Pathologic features and the classification of interstitial pneumonia of unknown etiology. Bull Chest Dis Res Inst Kyoto Univ 23(1–2), 1-18.
61. S. Nagai, M. Kitaichi, H. Itoh, et al. (1998) Idiopathic nonspecific interstitial pneumonia/fibrosis: Comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 12(5), 1010-1019.
62. V. Cottin, A.V. Donsbeck, D. Revel, et al. (1998) Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 158(4), 1286-1293.
63. Z.D. Daniil, F.C. Gilchrist, A.G. Nicholson, et al. (1999) A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 160(3), 899-905.
64. J.S. Park, K.S. Lee, J.S. Kim, et al. (1995) Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 195(3), 645-648.
65. T.E. Hartman, S.J. Swensen, D.M. Hansell, et al. (2000) Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 217(3), 701-705.
66. W.D. Travis, G. Hunninghake, T.E. King Jr, et al. (2008) Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 177(12), 1338-1347.
67. B.W. Kinder, H.R. Collard, L. Koth, et al. (2007) Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176(7), 691-697.
68. W.D. Travis, K. Matsui, J. Moss and V.J. Ferrans (2000) Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 24(1), 19-33.
69. A.G. Davison, B.E. Heard, W.A. McAllister and M.E. Turner-Warwick (1983) Cryptogenic organizing pneumonitis. Q J Med 52 382-394.
70. S.A. Yousem, R.H. Lohr and T.V. Colby (1997) Idiopathic bronchiolitis obliterans organizing pneumonia/cryptogenic organizing pneumonia with unfavorable outcome: pathologic predictors. Mod Pathol 10(9), 864-871.
71. T. Izumi, S. Nagai, K. Nishimura, et al. (1989) BALF cell findings in patients with BOOP, particularly in comparison with UIP. Nihon Kyobu Shikkan Gakkai Zasshi 27(4), 474-480.
72. T.J. King and R. Mortensen (1992) Cryptogenic organizing pneumonitis. Chest 102 8S-13S.
73. N.L. Müller, M.L. Guerry-Force, C.A. Staples, et al. (1987) Differential diagnosis of bronchiolitis obliterans with organizing pneumonia and usual interstitial pneumonia: clinical, functional, and radiologic findings. Radiology 162(1 Pt 1), 151-156.
74. J.F. Cordier, R. Loire and J. Brune (1989) Idiopathic bronchiolitis obliterans organizing pneumonia: definition of clinical profiles in a series of 16 patients. Chest 96 999-1004.
75. N.L. Müller, C.A. Staples and R.R. Miller (1990) Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. AJR Am J Roentgenol 154(5), 983-987.
76. K.S. Lee, P. Kullnig, T.E. Hartman and N.L. Müller (1994) Cryptogenic organizing pneumonia. CT findings in 43 patients. AJR Am J Roentgenol 62 543-546.
77. K.W. Preidler, D.M. Szolar, S. Moelleken, et al. (1996) Distribution pattern of computed tomography findings in patients with bronchiolitis obliterans organizing pneumonia. Invest Radiol 31(5), 251-255.
78. M. Akira, S. Yamamoto and S. Sakatani (1998) Bronchiolitis obliterans organizing pneumonia manifesting as multiple large nodules or masses. AJR Am J Roentgenol 170(2), 291-295.
79. T. Izumi, M. Kitaichi, K. Nishimura and S. Nagai (1992) Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. Chest 102(3), 715-719.
80. T.E. King Jr (1995) BOOP: An important cause of migratory pulmonary infiltrates? Eur Respir J 8(2), 193-195.
81. L.M. Bouchardy, J.E. Kuhlman, W.C. Ball Jr, et al. (1993) CT findings in bronchiolitis obliterans organizing pneumonia (BOOP) with radiographic, clinical, and histologic correlation. J Comput Assist Tomogr 17 352-357.
82. T.V. Colby (1992) Pathologic aspects of bronchiolitis obliterans organizing pneumonia. Chest 102(suppl 1), 38S-43S.
83. M. Kitaichi (1994) Bronchiolitis obliterans organizing pneumonia (BOOP). T. Takishima,(Eds) Basic and Clinical Aspects of Pulmonary Fibrosis Boca Raton, FL: CRC Press 463-488.
84. J.F. Cordier (1993) Cryptogenic organizing pneumonitis. Bronchiolitis obliterans organizing pneumonia. Clin Chest Med 14(4), 677-692.
85. D. Niewoehner, J. Kleinerman and D. Rice (1974) Pathologic changes in the the peripheral airways in young cigarette smokers. N Engl J Med 291 755-758.
86. J. Myers, C.F. Veal Jr, M.S. Shin and A.L. Katzenstein (1987) Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. Am Rev Respir Dis 135 880-884.
87. L.E. Heyneman, S. Ward, D.A. Lynch, et al. (1999) Respiratory bronchiolitis, respiratory bronchiolitis–associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? AJR Am J Roentgenol 173(6), 1617-1622.
88. S.A. Yousem, T.V. Colby and E.A. Gaensler (1989) Respiratory bronchiolitis–associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 64(11), 1373-1380.
89. J.L. Myers, C.F. Veal Jr, M.S. Shin and A.L. Katzenstein (1987) Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. Am Rev Respir Dis 135(4), 880-884.
90. T.E. King Jr (1993) Respiratory bronchiolitis–associated interstitial lung disease. Clin Chest Med 14(4), 693-698.
91. J. Moon, R.M. du Bois, T.V. Colby, et al. (1999) Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 54(11), 1009-1014.
92. S.A. Yousem (2006) Respiratory bronchiolitis–associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: A proposal. Mod Pathol 19(11), 1474-1479.
93. J. Portnoy, K.L. Veraldi, M.I. Schwarz, et al. (2007) Respiratory bronchiolitis–interstitial lung disease: long-term outcome. Chest 131(3), 664-671.
94. C.B. Carrington, E.A. Gaensler, R.E. Coutu, et al. (1978) Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 298(15), 801-809.
95. A.L. Katzenstein and J.L. Myers (1998) Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157(4 Pt 1), 1301-1315.
96. T.E. Hartman, S.L. Primack, S.J. Swensen, et al. (1993) Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 187(3), 787-790.
97. J.F. Gruden and W.R. Webb (1993) CT findings in a proved case of respiratory bronchiolitis. AJR Am J Roentgenol 161(1), 44-46.
98. A.G. Nicholson, A.C. Wotherspoon, T.C. Diss, et al. (1995) Pulmonary B-cell non-Hodgkin's lymphomas. The value of immunohistochemistry and gene analysis in diagnosis. Histopathology 26(5), 395-403.
99. A.G. Nicholson, A.C. Wotherspoon, T.C. Diss, et al. (1995) Reactive pulmonary lymphoid disorders. Histopathology 26(5), 405-412.
100. A.G. Nicholson, A.C. Wotherspoon, A.L. Jones, et al. (1996) Pulmonary B-cell non-Hodgkin's lymphoma associated with autoimmune disorders: a clinicopathological review of six cases. Eur Respir J 9(10), 2022-2025.
101. M.N. Koss (1993) Pulmonary lymphoproliferative disorders. Monogr Pathol 18(36), 145-194.
102. A. Herbert, M.T. Walters, M.I. Cawley and R.C. Godfrey (1985) Lymphocytic interstitial pneumonia identified as lymphoma of mucosa-associated lymphoid tissue. J Pathol 146(2), 129-138.
103. H.J. Schuurman, H.C. Gooszen, I.W. Tan, et al. (1987) Low-grade lymphoma of immature T-cell phenotype in a case of lymphocytic interstitial pneumonia and Sjögren's syndrome. Histopathology 11(11), 1193-1204.
104. S.I. Cha, M.B. Fessler, C.D. Cool, et al. (2006) Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur Respir J 28(2), 364-369.
105. C. Strimlan, E.C. Rosenow 3rd, L.H. Weiland and L.R. Brown (1978) Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 88 616-621.
106. A.A. Liebow and C.B. Carrington (1973) Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am 57 809-843.
107. C.V. Strimlan, E.C. Rosenow 3rd, M.B. Divertie and E.G. Harrison Jr (1976) Pulmonary manifestations of Sjögren's syndrome. Chest 70(03), 354-361.
108. W.E. DeCoteau, D. Tourville, J.L. Ambrus, et al. (1974) Lymphoid interstitial pneumonia and autoerythrocyte sensitization syndrome. A case with deposition of immunoglobulins on the alveolar basement membrane. Arch Intern Med 134(3), 519-522.
109. P.R. Julsrud, L.R. Brown, C.Y. Li, et al. (1978) Pulmonary processes of mature-appearing lymphocytes: pseudolymphoma, well-differentiated lymphocytic lymphoma, and lymphocytic interstitial pneumonitis. Radiology 127(2), 289-296.
110. M.I. Schwarz (1998) A man with dyspnea, productive cough, and chest radiograph showing hyperinflation and a diffuse nodular pattern. Chest 113(4), 1123-1124.
111. T. Johkoh, K. Ichikado, M. Akira, et al. (2000) Lymphocytic interstitial pneumonia: follow-up CT findings in 14 patients. J Thorac Imaging 15(3), 162-167.
112. A. Macfarlane and D. Davies (1973) Diffuse lymphoid interstitial pneumonia. Thorax 28(6), 768-776.
113. C. Strimlan, E.C. Rosenow 3rd, L.H. Weiland and L.R. Brown (1978) Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 88 616-621.
114. T. Johkoh, N.L. Müller, H.A. Pickford, et al. (1999) Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 212(2), 567-572.
115. C.I. Silva, J.D. Flint, R.D. Levy and N.L. Müller (2006) Diffuse lung cysts in lymphoid interstitial pneumonia: high-resolution CT and pathologic findings. J Thorac Imaging 21(3), 241-244.
116. C. Lohrmann, M. Uhl, K. Warnatz, et al. (2004) High-resolution CT imaging of the lung for patients with primary Sjögren's syndrome. Eur J Radiol 52(2), 137-143.
117. K. Torii, K. Ogawa, Y. Kawabata, et al. (1994) Lymphoid interstitial pneumonia as a pulmonary lesion of idiopathic plasmacytic lymphadenopathy with hyperimmunoglobulinemia. Intern Med 33(4), 237-241.
118. P.R. Julsrud, L.R. Brown, C.Y. Li, et al. (1978) Pulmonary processes of mature-appearing lymphocytes: pseudolymphoma, well-differentiated lymphocytic lymphoma, and lymphocytic interstitial pneumonitis. Radiology 127 289-296.
119. C.V. Strimlan (2001) Pulmonary function in patients with primary Sjögren's syndrome. Ann Rheum Dis 60(4), 429.
120. A. Palmas, A. Tefferi, J.L. Myers, et al. (1998) Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 100(4), 680-687.
121. M. Grieco and P. Chinoy-Acharya (1985) Lymphoid interstitial pneumonia associated with the acquired immune deficiency syndrome. Am Rev Respir Dis 131 952-955.
122. W.E. Berdon, R.B. Mellins, S.J. Abramson and C. Ruzal-Shapiro (1993) Pediatric HIV infection in its second decade—the changing pattern of lung involvement. Clinical, plain film, and computed tomographic findings. Radiol Clin North Am 31(3), 453-463.
123. M.O. Ikeogu, B. Wolf and S. Mathe (1997) Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child 76(2), 124-128.
124. M.D. Khare and M. Sharland (1999) Pulmonary manifestations of pediatric HIV infection. Indian J Pediatr 66(6), 895-904.
125. J.A. Church (1985) Lymphoid interstitial pneumonia and rheumatoid arthritis. J Pediatr 107(3), 485.
126. L. Black and S. Katz (1977) Respiratory Disease: Task Force Report on Problems, Research Approaches, Needs Washington, DC: Department of Health, Education, and Welfare, National Heart and Lung Institute
127. J. Banks, C. Banks, B. Cheong, et al. (1992) An epidemiological and clinical investigation of pulmonary function and respiratory symptoms in patients with rheumatoid arthritis. Q J Med 85 795-806.
128. G.S. Cheema and F.P. Quismorio Jr (2001) Interstitial lung disease in systemic sclerosis. Curr Opin Pulm Med 7(5), 283-290.
129. O.A. Minai, R.A. Dweik and A.C. Arroliga (1998) Manifestations of scleroderma pulmonary disease. Clin Chest Med. 19(4), 713-731. viii–ix
130. G.S. Cheema and F.P. Quismorio Jr (2000) Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med 6(5), 424-429.
131. S. Murin, H.P. Wiedemann and R.A. Matthay (1998) Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med. 19(4), 641-665. viii
132. B.F. Dickey and A.R. Myers (1984) Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum. 14(1), 60-76.
133. I. Ito, S. Nagai, M. Kitaichi, et al. (2005) Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171(6), 632-638.
134. M. Koyama, T. Johkoh, O. Honda, et al. (2001) Pulmonary involvement in primary Sjögren's syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging. 16(4), 290-296.
135. P.K. Sarkar, N. Patel, R.A. Furie and A. Talwar (2009) Pulmonary manifestations of primary Sjögren's syndrome. Indian J Chest Dis Allied Sci. 51(2), 93-101.
136. U.B. Prakash (1998) Respiratory complications in mixed connective tissue disease. Clin Chest Med. 19(4), 733-746. ix
137. I. Tillie-Leblond, M. Wislez, D. Valeyre, et al. (2008) Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax 63(1), 53-59.
138. P. Ellman and R.E. Ball (1948) “Rheumatoid disease” with joint and pulmonary manifestations. BMJ 2 816-820.
139. E. Gabbay, R. Tarala, R. Will, et al. (1997) Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 156(2 Pt 1), 528-535.
140. J.M. Anaya, L. Diethelm, L.A. Ortiz, et al. (1995) Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 24(4), 242-254.
141. M. Hakala (1988) Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest 93(1), 114-118.
142. B.H. Athreya, R.A. Doughty, M. Bookspan, et al. (1980) Pulmonary manifestations of juvenile rheumatoid arthritis. A report of eight cases and review. Clin Chest Med 1(3), 361-374.
143. K.G. Saag, S. Kolluri, R.K. Koehnke, et al. (1996) Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum 39(10), 1711-1719.
144. M. Akira, M. Sakatani and H. Hara (1999) Thin-section CT findings in rheumatoid arthritis–associated lung disease: CT patterns and their courses. J Comput Assist Tomogr 23(6), 941-948.
145. M. Remy-Jardin, J. Remy, B. Cortet, et al. (1994) Lung changes in rheumatoid arthritis: CT findings. Radiology 193(2), 375-382.
146. G.W. Hunninghake and A.S. Fauci (1979) Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 119(3), 471-503.
147. R. Hubbard and A. Venn (2002) The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis. Rheumatology (Oxford) 41(6), 676-679.
148. O. Laitinen, M. Nissilä, Y. Salorinne and P. Aalto (1975) Pulmonary involvement in patients with rheumatoid arthritis. Scand J Respir Dis 56 297-304.
149. H.K. Lee, D.S. Kim, B. Yoo, et al. (2005) Histopathologic pattern and clinical features of rheumatoid arthritis–associated interstitial lung disease. Chest 127(6), 2019-2027.
150. M.I. Schwarz, R.A. Matthay, S.A. Sahn, et al. (1976) Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 55(1), 89-104.
151. D. Khanna, K.K. Brown, P.J. Clements, et al. (2010) Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials. Clin Exp Rheumatol. 28(2 Suppl 58), S55-S62.
152. G.W. Hunninghake, J.E. Gadek, O. Kawanami, et al. (1979) Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol 97 149-206.
153. D. Bouros, A.U. Wells, A.G. Nicholson, et al. (2002) Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165(12), 1581-1586.
154. D.S. Kim, B. Yoo, J.S. Lee, et al. (2002) The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 19(2), 121-127.
155. E.A. Kim, T. Johkoh, K.S. Lee, et al. (2001) Interstitial pneumonia in progressive systemic sclerosis: serial high-resolution CT findings with functional correlation. J Comput Assist Tomogr 25(5), 757-763.
156. F. Cozzi, M. Chiesura Corona, M. Rizzi, et al. (2001) Lung fibrosis quantified by HRCT in scleroderma patients with different disease forms and ANA specificities. Reumatismo 53(1), 55-62.
157. K. Yamane, H. Ihn, Y. Asano, et al. (2000) Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology (Oxford) 39(11), 1269-1271.
158. D.A. Johnson, W.E. Drane, J. Curran, et al. (1989) Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration? Arch Intern Med 149(3), 589-593.
159. A. Montesi, A. Pesaresi, M.L. Cavalli, et al. (1991) Oropharyngeal and esophageal function in scleroderma. Dysphagia 6(4), 219-223.
160. D.P. Tashkin, R. Elashoff, P.J. Clements, et al. (2007) Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med 176(10), 1026-1034.
161. P.A. McSweeney, R.A. Nash, K.M. Sullivan, et al. (2002) High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood 100(5), 1602-1610.
162. E. Dubois and D.L. Tufanelli (1964) Clinical manifestations of systemic lupus erythematosus. JAMA 190 104-111.
163. H. Eisenberg, E.L. Dubois, R.P. Sherwin and O.J. Balchum (1973) Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med 79 37-45.
164. R.B. Gammon, T.A. Bridges, H. al-Nezir, et al. (1992) Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest 102 1171-1174.
165. J.L. Myers and A.A. Katzenstein (1986) Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 85(5), 552-556.
166. M.Y. Chang, J.T. Fang, Y.C. Chen and C.C. Huang (2002) Diffuse alveolar hemorrhage in systemic lupus erythematosus: a single center retrospective study in Taiwan. Ren Fail 24(6), 791-802.
167. A.S. Santos-Ocampo, B.F. Mandell and B.J. Fessler (2000) Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest 118(4), 1083-1090.
168. R.A. Matthay, M.I. Schwarz, T.L. Petty, et al. (1974) Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases with acute lupus pneumonitis. Medicine 54 397-409.
169. J.S. Kim, K.S. Lee, E.M. Koh, et al. (2000) Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings. J Comput Assist Tomogr 24(1), 9-18.
170. M.D. Hughson, Z. He, J. Henegar and R. McMurray (2001) Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus. Arch Pathol Lab Med 125(4), 475-483.
171. A.A. Bankier, H.P. Kiener, M.N. Wiesmayr, et al. (1995) Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology 196(3), 835-840.
172. H.M. Fenlon, M. Doran, S.M. Sant and E. Breatnach (1996) High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol 166(2), 301-307.
173. S.M. Sant, M. Doran, H.M. Fenelon and E.S. Breatnach (1997) Pleuropulmonary abnormalities in patients with systemic lupus erythematosus: assessment with high resolution computed tomography, chest radiography and pulmonary function tests. Clin Exp Rheumatol 15(5), 507-513.
174. G.C. Ooi, H. Ngan, W.C. Peh, et al. (1997) Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT. Clin Radiol 52(10), 775-781.
175. I. Susanto and J.I. Peters (1997) Acute lupus pneumonitis with normal chest radiograph. Chest 111(6), 1781-1783.
176. N.E. Anderson and M.R. Ali (1984) The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension. Ann Rheum Dis 43(5), 760-763.
177. H.S. Howe, M.L. Boey, K.Y. Fong and P.H. Feng (1988) Pulmonary haemorrhage, pulmonary infarction, and the lupus anticoagulant. Ann Rheum Dis 47(10), 869-872.
178. W.R. Auger, P. Permpikul and K.M. Moser (1995) Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report. Am J Med 99(4), 392-396.
179. J.D. Urman and N.F. Rothfield (1977) Corticosteroid treatment in systemic lupus erythematosus. Survival studies. JAMA 238(21), 2272. 1176
180. S. Rosner, E.M. Ginzler, H.S. Diamond, et al. (1982) A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 25(6), 612-617.
181. A. Bohan, J.B. Peter, R.L. Bowman and C.M. Pearson (1977) Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 56(4), 255-286.
182. A. Bohan (1988) History and classification of polymyositis and dermatomyositis. Clin Dermatol 6(2), 3-8.
183. T. Nobutoh, M. Kohda, Y. Doi and H. Ueki (1998) An autopsy case of dermatomyositis with rapidly progressive diffuse alveolar damage. J Dermatol 25(1), 32-36.
184. H.D. Tazelaar, R.W. Viggiano, J. Pickersgill and T.V. Colby (1990) Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 141(3), 727-733.
185. W.W. Douglas, H.D. Tazelaar, T.E. Hartman, et al. (2001) Polymyositis-dermatomyositis–associated interstitial lung disease. Am J Respir Crit Care Med 164(7), 1182-1185.
186. N. Hepper, R.H. Ferguson and F.M. Howard (1964) Three types of pulmonary involvement in polymyositis. Med Clin North Am 48 1031-1042.
187. J. Benbassat, D. Gefel, K. Larholt, et al. (1985) Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum 28(3), 249-255.
188. J. Ikezoe, T. Johkoh, N. Kohno, et al. (1996) High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging 11(4), 250-259.
189. K. Whaley and M.A. Alspaugh (1985) Sjögren's syndrome. H. Kelley, E.D. Harris, Jr,S. Ruddy, C.B. Sledge,(Eds) Textbook of Rheumatology 2nd ed Philadelphia: WB Saunders 956.
190. H.H. Baruch, H. Firooznia, J.P. Sackler, et al. (1977) Pulmonary disorders associated with Sjögren's syndrome. Rev Interam Radiol 2(2), 77-81.
191. T. Franquet, A. Giménez, J.M. Monill, et al. (1997) Primary Sjögren's syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 169(3), 655-658.
192. D. Deheinzelin, V.L. Capelozzi, R.A. Kairalla, et al. (1996) Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 154(3 Pt 1), 794-799.
193. J.D. Reveille, R.W. Wilson, T.T. Provost, et al. (1984) Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med 101(6), 748-756.
194. C.A. Meyer, J.S. Pina, D. Taillon and J.D. Godwin (1997) Inspiratory and expiratory high-resolution CT findings in a patient with Sjögren's syndrome and cystic lung disease. AJR Am J Roentgenol 168(1), 101-103.
195. L.A. Hansen, U.B. Prakash and T.V. Colby (1989) Pulmonary lymphoma in Sjögren's syndrome. Mayo Clin Proc 64(8), 920-931.
196. M. Kokosi, E.C. Riemer and K.B. Highland (2010) Pulmonary involvement in Sjögren syndrome. Clin Chest Med 31(3), 489-500.
197. C.B. Carrington, et al. (1969) Chronic eosinophilic pneumonia. N Engl J Med 280 787-798.
198. A. Liebow and C. Carrington (1969) The eosinophilic pneumonias. Medicine (Baltimore) 48 251-285.
199. E. Gaensler and C. Carrington (1977) Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema. AJR Am J Roentgenol 128 1-13.
200. J. Mayo, N.L. Müller, J. Road, et al. (1989) Chronic eosinophilic pneumonia: CT findings in six cases. AJR Am J Roentgenol 153 727-730.
201. J.A. Copper Jr (1997) Drug-induced lung disease. Adv Intern Med 42 231-268.
202. P.H. Camus, P. Foucher, P.H. Bonniaud and K. Ask (2001) Drug-induced infiltrative lung disease. Eur Respir J Suppl 32 93s-100s.
203. M. Ozkan, R.A. Dweik and M. Ahmad (2001) Drug-induced lung disease. Cleve Clin J Med 68(9), 782-785. 789–795
204. M.L. Cuellar (2002) Drug-induced vasculitis. Curr Rheumatol Rep 4(1), 55-59.
205. R. Ruangchira-Urai, T.V. Colby, J. Klein, et al. (2008) Nodular amiodarone lung disease. Am J Surg Pathol 32(11), 1654-1660.
206. P. Camus, J.N. Lombard, M. Perrichon, et al. (1989) Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone. Thorax. 44(9), 711-715.
207. J.I. Kennedy, J.L. Myers, V.J. Plumb and J.D. Fulmer (1987) Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlations. Arch Intern Med 147(1), 50-55.
208. A.W. Musk and J.A. Pollard (1979) Pindolol and pulmonary fibrosis. BMJ 2(6190), 581-582.
209. A. Sandler, R. Gray, M.C. Perry, et al. (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med. 355(24), 2542-2550.
210. J.R. Iacovino, J. Leitner, A.K. Abbas, et al. (1976) Fatal pulmonary reaction from low doses of bleomycin. An idiosyncratic tissue response. JAMA 235(12), 1253-1255.
211. M.A. Luna, C.W. Bedrossian, B. Lichtiger and P.A. Salem (1972) Interstitial pneumonitis associated with bleomycin therapy. Am J Clin Pathol. 58(5), 501-510.
212. M.L. Feingold and L.G. Koss (1969) Effects of long-term administration of busulfan. Report of a patient with generalized nuclear abnormalities, carcinoma of vulva, and pulmonary fibrosis. Arch Intern Med 124(1), 66-71.
213. W.A. Littler, J.M. Kay, P.S. Hasleton and D. Heath (1969) Busulphan lung. Thorax 24(6), 639-655.
214. C.M. Lombard, A. Churg and S. Winokur (1987) Pulmonary veno-occlusive disease following therapy for malignant neoplasms. Chest 92(5), 871-876.
215. S.M. Mitsudo, E.S. Greenwald, B. Banerji and L.G. Koss (1984) BCNU (1,3- bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes. Cancer 54(4), 751-755.
216. J.M. Forrester, A.W. Steele, J.A. Waldron and P.E. Parsons (1990) Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am Rev Respir Dis 142(2), 462-467.
217. R.J. Murray, R.J. Albin, W. Mergner and G.J. Criner (1988) Diffuse alveolar hemorrhage temporally related to cocaine smoking. Chest 93(2), 427-429.
218. F.W. Abdel Karim, R.E. Ayash, C. Allam and P.A. Salem (1983) Pulmonary fibrosis after prolonged treatment with low-dose cyclophosphamide. A case report. Oncology 40(3), 174-176.
219. A.R. Patel, P.C. Shah, H.L. Rhee, et al. (1976) Cyclophosphamide therapy and interstitial pulmonary fibrosis. Cancer 38(4), 1542-1549.
220. J.I. Spector, H. Zimbler and J.S. Ross (1979) Early-onset cyclophosphamide-induced interstitial pneumonitis. JAMA 242(26), 2852-2854.
221. R.E. Slavin, J.C. Millan and G.M. Mullins (1975) Pathology of high dose intermittent cyclophosphamide therapy. Hum Pathol 6(6), 693-709.
222. W.L. Read, J.E. Mortimer and J. Picus (2002) Severe interstitial pneumonitis associated with docetaxel administration. Cancer 94(3), 847-853.
223. P. Pfitzenmeyer, P. Foucher, G. Dennewald, et al. (1996) Pleuropulmonary changes induced by ergoline drugs. Eur Respir J 9(5), 1013-1019.
224. V. Liu, D.A. White, M.F. Zakowski, et al. (2007) Pulmonary toxicity associated with erlotinib. Chest 132(3), 1042-1044.
225. A. Gurjal, T. An, M. Valdivieso and G.P. Kalemkerian (1999) Etoposide-induced pulmonary toxicity. Lung Cancer 26(2), 109-112.
226. A. Inoue, Y. Saijo, M. Maemondo, et al. (2003) Severe acute interstitial pneumonia and gefitinib. Lancet 361(9352), 137-139.
227. E. Briasoulis, M. Froudarakis, H.J. Milionis, et al. (2000) Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor support. Respiration 67(6), 680-683.
228. R. Tomioka and T.E. King Jr (1997) Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease. Am J Respir Crit Care Med 155(3), 1011-1020.
229. M.L. Warnock, G.G. Ghahremani, C. Rattenborg, et al. (1972) Pulmonary complication of heroin intoxication. Aspiration pneumonia and diffuse bronchiectasis. JAMA 219(8), 1051-1053.
230. S. Karne, C. D'Ambrosio, O. Einarsson and P.G. O'Connor (1999) Hypersensitivity pneumonitis induced by intranasal heroin use. Am J Med 107(4), 392-395.
231. A.G. Petersen, M. Dodge and F.C. Helwig (1959) Pulmonary changes associated with hexamethonium therapy. Arch Intern Med 103 285-288.
232. H.M. Perry Jr, R.M. O'Neal and W.A. Thomas (1957) Pulmonary disease following chronic chemical ganglionic blockade. Am J Med 22 37-50.
233. C. Beaudry and L. Laplante (1973) Severe allergic pneumonitis from hydrochlorothiazide. Ann Intern Med 78(2), 251-253.
234. A. Kaufman, E. Montilla, M. Helfgott, et al. (1973) Pneumonitis and hydrochlorothiazide. Ann Intern Med 79(2), 282-283.
235. M.R. Dorn and B.K. Walker (1981) Noncardiogenic pulmonary edema associated with hydrochlorothiazide therapy. Chest 79(4), 482-483.
236. B. Tengstrand, S. Ernestam, I.L. Engvall, et al. (2005) TNF blockade in rheumatoid arthritis can cause severe fibrosing alveolitis. Six case reports. Lakartidningen 102(49), 3788-3790. 3793
237. C. Cordonnier, J.P. Vernant, P. Mital, et al. (1983) Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia. Cancer 51(10), 1814-1818.
238. J.L. Myers (1997) Pathology of drug-induced lung disease. A.L. Katzenstein,(Eds) Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease Philadelphia: WB Saunders 81-111.
239. S. Imokawa, T.V. Colby, K.O. Leslie and R.A. Helmers (2000) Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 15(2), 373-381.
240. L. Bentur, Y. Bar-Kana, E. Livni, et al. (1997) Severe minocycline-induced eosinophilic pneumonia: extrapulmonary manifestations and the use of in vitro immunoassays. Ann Pharmacother 31(6), 733-735.
241. D. Piperno, C. Donné, R. Loire and J.F. Cordier (1995) Bronchiolitis obliterans organizing pneumonia associated with minocycline therapy: a possible cause. Eur Respir J 8(6), 1018-1020.
242. R.E. Waldhorn, E. Tsou, F.P. Smith and D.M. Kerwin (1984) Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma. Med Pediatr Oncol 12(6), 394-396.
243. J.W. Fielding, J. Crocker, R.A. Stockley and V.S. Brookes (1979) Interstitial fibrosis in a patient treated with 5-fluorouracil and mitomycin C. BMJ 2(6189), 551-552.
244. K.S. Israel, R.E. Brashear, H.M. Sharma, et al. (1973) Pulmonary fibrosis and nitrofurantoin. Am Rev Respir Dis 108(2), 353-356.
245. M. Geller, H.A. Dickie, D.A. Kass, et al. (1976) The histopathology of acute nitrofurantoin-associated pneumonitis. Ann Allergy 37(4), 275-279.
246. F. Magee, J.L. Wright, N. Chan, et al. (1986) Two unusual pathological reactions to nitrofurantoin: case reports. Histopathology 10(7), 701-706.
247. J.P. Ayoub, L. North, J. Greer, et al. (1997) Pulmonary changes in patients with lymphoma who receive paclitaxel. J Clin Oncol 15(6), 2476.
248. G.R. Epler, G.L. Snider, E.A. Gaensler, et al. (1979) Bronchiolitis and bronchitis in connective tissue disease. A possible relationship to the use of penicillamine. JAMA 242(6), 528-532.
249. I. Sternlieb, B. Bennett and I.H. Scheinberg (1975) d-Penicillamine induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med 82(5), 673-676.
250. D. Davies and J.K. Jones (1980) Pulmonary eosinophilia caused by penicillamine. Thorax 35(12), 957-958.
251. D.W. Chamberlain, R.H. Hyland and D.J. Ross (1986) Diphenylhydantoin-induced lymphocytic interstitial pneumonia. Chest 90(3), 458-460.
252. J.R. Michael and M.L. Rudin (1981) Acute pulmonary disease caused by phenytoin. Ann Intern Med 95(4), 452-454.
253. V.A. Dohner, H.P. Ward and R.E. Standord (1972) Alveolitis during procarbazine, vincristine and cyclophosphamide therapy. Chest 62(5), 636-639.
254. R.J. Farney, A.H. Morris, J.D. Armstrong and S. Hammer (1977) Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone. Am Rev Respir Dis 115(1), 135-145.
255. L.W. Horton, A.G. Chappell and D.E. Powell (1977) Diffuse interstitial pulmonary fibrosis complicating Hodgkin's disease. Br J Dis Chest 71(1), 44-48.
256. R.J. Gonzalez-Rothi, D.S. Zander and P.R. Ros (1995) Fluoxetine hydrochloride (Prozac)-induced pulmonary disease. Chest 107(6), 1763-1765.
257. C. Burton, R. Kaczmarski and R. Jan-Mohamed (2003) Interstitial pneumonitis related to rituximab therapy. N Engl J Med 348(26), 2690-2691. discussion 2690–2691
258. S.D. Parry, et al. (2002) Sulphasalazine and lung toxicity. Eur Respir J 19(4), 756-764.
259. W.D. Travis, M.E. Kalafer, H.S. Robin and F.J. Luibel (1990) Hypersensitivity pneumonitis and pulmonary vasculitis with eosinophilia in a patient taking an l-tryptophan preparation. Ann Intern Med 112(4), 301-303.
260. C.K. Catton, J.C. Elmer, A.C. Whitehouse, et al. (1991) Pulmonary involvement in the eosinophilia-myalgia syndrome. Chest 99(2), 327-329.
261. D.B. Calvo 3rd, S.S. Legha, E.M. McKelvey, et al. (1981) Zinostatin-related pulmonary toxicity. Cancer Treat Rep 65(1–2), 165-167.
262. R.J. Zitnik and R.A. Matthay (1998) Drug-induced lung disease. M.I. Schwartz, T.E. King,(Eds) Interstitial Lung Disease London: BC Decker 423-449.
263. S. Kudoh, H. Kato, Y. Nishiwaki, et al. (2008) Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study. Am J Respir Crit Care Med. 177(12), 1348-1357.
264. H.D. Sostman, R.A. Matthay, C.E. Putman and G.J. Smith (1976) Methotrexate-induced pneumonitis. Medicine (Baltimore) 55(5), 371-388.
265. T.A. Goodman and R.P. Polisson (1994) Methotrexate: adverse reactions and major toxicities. Rheum Dis Clin North Am 20(2), 513-528.
266. C.W. Bedrossian, W.C. Miller and M.A. Luna (1979) Methotrexate-induced diffuse interstitial pulmonary fibrosis. South Med J 72(3), 313-318.
267. D.A. Zisman, W.J. McCune, G. Tino and J.P. Lynch 3rd (2001) Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis 18(3), 243-252.
268. J.I. Kennedy, J.L. Myers, V.J. Plumb and J.D. Fulmer (1987) Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlations. Arch Intern Med 147(1), 50-55.
269. R.E. Dusman, M.S. Stanton, W.M. Miles, et al. (1990) Clinical features of amiodarone-induced pulmonary toxicity. Circulation 82(1), 51-59.
270. L.S. Newman, C.S. Rose, E.A. Bresnitz, et al. (2004) A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170(12), 1324-1330.
271. A.E. Fraire, K.K. Guntupalli, S.D. Greenberg, et al. (1993) Amiodarone pulmonary toxicity: a multidisciplinary review of current status. South Med J 86(1), 67-77.
272. A.A. Nicholson and C. Hayward (1989) The value of computed tomography in the diagnosis of amiodarone-induced pulmonary toxicity. Clin Radiol 40(6), 564-567.
273. J.E. Kuhlman, C. Teigen, H. Ren, et al. (1990) Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology 177(1), 121-125.
274. J.L. Myers, J.I. Kennedy and V.J. Plumb (1987) Amiodarone lung: Pathologic findings in clinically toxic patients. Hum Pathol 18(4), 349-354.
275. W.J. Martin 2nd and E.C. Rosenow 3rd (1988) Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I). Chest 93(5), 1067-1075.
276. W.J. Martin 2nd and E.C. Rosenow 3rd (1988) Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2). Chest 93(6), 1242-1248.
277. R.J. Gonzalez-Rothi, S.E. Hannan, C.I. Hood and D.A. Franzini (1987) Amiodarone pulmonary toxicity presenting as bilateral exudative pleural effusions. Chest 92(1), 179-182.
278. R. Ruangchira-Urai, T.V. Colby, J. Klein, et al. (2008) Nodular amiodarone lung disease. Am J Surg Pathol. 32(11), 1654-1660.
279. D.L. Wood, M.J. Osborn, J. Rooke and D.R. Holmes Jr (1985) Amiodarone pulmonary toxicity: report of two cases associated with rapidly progressive fatal adult respiratory distress syndrome after pulmonary angiography. Mayo Clin Proc 60(9), 601-603.
280. W. Van Mieghem, L. Coolen, I. Malysse, et al. (1994) Amiodarone and the development of ARDS after lung surgery. Chest 105(6), 1642-1645.
281. J.R. Durant, M.J. Norgard, T.M. Murad, et al. (1979) Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU). Ann Intern Med 90(2), 191-194.
282. A. Lieberman, M. Ruoff, E. Estey, et al. (1980) Irreversible pulmonary toxicity after single course of BCNU. Am J Med Sci 279(1), 53-56.
283. J.P. Litam, D.H. Dail, G. Spitzer, et al. (1981) Early pulmonary toxicity after administration of high-dose BCNU. Cancer Treat Rep 65(1–2), 39-44.
284. T.M. Cao, R.S. Negrin, K.E. Stockerl-Goldstein, et al. (2000) Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 6(4), 387-394.
285. P.Y. Holoye, D.E. Jenkins and S.D. Greenberg (1976) Pulmonary toxicity in long-term administration of BCNU. Cancer Treat Rep 60(11), 1691-1694.
286. B.R. O'Driscoll, P.S. Hasleton, P.M. Taylor, et al. (1990) Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 323(6), 378-382.
287. J.M. Parish, J.R. Muhm and K.O. Leslie (2003) Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation. Mayo Clin Proc 78(5), 630-634.
288. W. Littler, J.M. Kay, P.S. Hasleton and D. Heath (1969) Busulphan lung. Thorax 24(6), 639-655.
289. J.A. Cooper Jr, D.A. White and R.A. Matthay (1986) Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis 133(2), 321-340.
290. H. Kreisman and N. Wolkove (1992) Pulmonary toxicity of antineoplastic therapy. Semin Oncol 19(5), 508-520.
291. P.Y. Holoye, M.A. Luna, B. MacKay and C.W. Bedrossian (1978) Bleomycin hypersensitivity pneumonitis. Ann Intern Med 8 47-49.
292. J.G. Hay, P.L. Haslam, A. Dewar, et al. (1987) Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats. Thorax 42(5), 374-382.
293. G. Borzone, R. Moreno, R. Urrea, et al. (2001) Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 163(7), 1648-1653.
294. H.H. Lien, U. Brodahl, R. Telhaug, et al. (1985) Pulmonary changes at computed tomography in patients with testicular carcinoma treated with cis-platinum, vinblastine and bleomycin. Acta Radiol Diagn (Stockh) 26(5), 507-510.
295. K.B. Adler, L.M. Callahan and J.N. Evans (1986) Cellular alterations in the alveolar wall in bleomycin-induced pulmonary fibrosis in rats. An ultrastructural morphometric study. Am Rev Respir Dis 133(6), 1043-1048.
296. J.S. Lazo (1999) Bleomycin. Cancer Chemother Biol Response Modif 18 39-45.
297. R.P. Bowler, M. Nicks, K. Warnick and J.D. Crapo (2002) Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 282(4), L719-L726.
298. D.J. Taatjes, K.O. Leslie, M. von Turkovich, et al. (1991) Alveolocapillary remodeling in bleomycin-induced rat lung injury: interpretation from lectin-binding studies. Prog Histochem Cytochem 23(1–4), 194-199.
299. M.H. Cohen, G.A. Williams, R. Sridhara, et al. (2003) FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. Oncologist 8(4), 303-306.
300. M. Ando, I. Okamoto, N. Yamamoto, et al. (2006) Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol 24(16), 2549-2556.
301. A.J. Ostör, E.R. Chilvers, M.F. Somerville, et al. (2006) Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. J Rheumatol 33(3), 622-628.
302. W. Stern and K. Subbarao (1983) Pulmonary complications of drug addiction. Semin Roentgenol 28 183-197.
303. J. Abraham and C. Brambilla (1980) Particle size for differentiation between inhalation and injection pulmonary talcosis. Environ Res 21(1), 94-96.
304. J.L. Abraham (1984) Identification and quantitative analysis of tissue particulate burden. Ann N Y Acad Sci 428 60-67.
305. J.L. Abraham, B.R. Burnett and A. Hunt (1991) Development and use of a pneumoconiosis database of human pulmonary inorganic particulate burden in over 400 lungs. Scanning Microsc 5(1), 95-104. discussion 105–108
306. J. Tomashefski and C. Hirsch (1980) The pulmonary vascular lesions of intravenous drug abuse. Hum Pathol 11 133-145.
307. E. Crouch and A. Churg (1983) Progressive massive fibrosis of the lung secondary to intravenous injection of talc. A pathologic and mineralogical analysis. Am J Clin Pathol 80 520-526.
308. E.J. Stern, M.S. Frank, J.F. Schmutz, et al. (1994) Panlobular pulmonary emphysema caused by i.v. injection of methylphenidate (Ritalin): findings on chest radiographs and CT scans. AJR Am J Roentgenol 162 555-560.
309. M. Schiavina, V. Di Scioscio, P. Contini, et al. (2007) Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am J Respir Crit Care Med 176(1), 96-98.
310. O.Y. Cheung, J.R. Muhm, R.A. Helmers, et al. (2003) Surgical pathology of granulomatous interstitial pneumonia. Ann Diagn Pathol 7(2), 127-138.
311. G.W. Hunninghake, U. Costabel, M. Ando, et al. (1999) ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16(2), 149-173.
312. R.G. Stirling, P. Cullinan and R.M.P. Du Bois (1998) Sarcoidosis. M.I. Schwartz, T.E. King,(Eds) Interstitial Lung Disease London: BC Decker 279-322.
313. N. Milman and O. Selroos (1990) Pulmonary sarcoidosis in the Nordic countries 1950–1982. Epidemiology and clinical picture. Sarcoidosis 7(1), 50-57.
314. N. Milman and O. Selroos (1990) Pulmonary sarcoidosis in the Nordic countries 1950–1982. II. Course and prognosis. Sarcoidosis 7(2), 113-118.
315. P.E. Sartwell and L.B. Edwards (1974) Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol 99(4), 250-257.
316. D.A. Lynch, W.R. Webb, G. Gamsu, et al. (1989) Computed tomography in pulmonary sarcoidosis. J Comput Assist Tomogr 13 405-410.
317. J.E. Kuhlman, E.K. Fishman, U.M. Hamper, et al. (1989) The computed tomographic spectrum of thoracic sarcoidosis. Radiographics 9(3), 449-466.
318. N.L. Müller, P. Kullnig and R.R. Miller (1989) The CT findings of pulmonary sarcoidosis: analysis of 25 patients. AJR Am J Roentgenol 152(6), 1179-1182.
319. S.P. Padley, A.R. Padhani, A. Nicholson and D.M. Hansell (1996) Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT. Clin Radiol 51(11), 807-810.
320. M. Abehsera, D. Valeyre, P. Grenier, et al. (2000) Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 174(6), 1751-1757.
321. J.P. Battesti, G. Saumon, D. Valeyre, et al. (1982) Pulmonary sarcoidosis with an alveolar radiographic pattern. Thorax 37 448-452.
322. M.J. Gilman and K.P. Wang (1980) Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis 122(5), 721-724.
323. R.M. Hsu, A.F. Connors Jr and J.F. Tomashefski Jr (1996) Histologic, microbiologic, and clinical correlates of the diagnosis of sarcoidosis by transbronchial biopsy. Arch Pathol Lab Med 120(4), 364-368.
324. D. Freiman and H. Hardy (1970) Beryllium disease: the relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. Beryllium Case Registry. Hum Pathol 1 25-44.
325. A. Matilla, H. Galera, E. Pascual and R. Carapeto (1973) Chronic berylliosis. Br J Dis Chest 67 308-314.
326. J.M. Aronchik, M.D. Rossman and W.T. Miller (1987) Chronic beryllium disease: diagnosis, radiographic findings, and correlation with pulmonary function tests. Radiology 163 677-678.
327. D. Kriebel, J.D. Brain, N.L. Sprince and H. Kazemi (1988) The pulmonary toxicity of beryllium. Am Rev Respir Dis 137(2), 464-473.
328. D. Kriebel, N.L. Sprince, E.A. Eisen and I.A. Greaves (1988) Pulmonary function in beryllium workers: assessment of exposure. Br J Ind Med 45(2), 83-92.
329. D. Kriebel, N.L. Sprince, E.A. Eisen, et al. (1988) Beryllium exposure and pulmonary function: a cross sectional study of beryllium workers. Br J Ind Med 45(3), 167-173.
330. L.A. Maier, J.W. Martyny, J. Liang and M.D. Rossman (2008) Recent chronic beryllium disease in residents surrounding a beryllium facility. Am J Respir Crit Care Med 177(9), 1012-1017.
331. O. Kawanami, F. Basset, R. Barrios, et al. (1983) Hypersensitivity pneumonitis in man: light- and electron-microscopic studies of 18 lung biopsies. Am J Pathol 110 275-289.
332. J. Salvaggio and R. Karr (1979) Hypersensitivity pneumonitis: state of the art. Chest 75(suppl 2), 270-274.
333. L.G. Wild and M. Lopez (2001) Hypersensitivity pneumonitis: a comprehensive review. J Investig Allergol Clin Immunol 11(1), 3-15.
334. S.J. Bourke, J.C. Dalphin, G. Boyd, et al. (2001) Hypersensitivity pneumonitis: current concepts. Eur Respir J Suppl 32 81s-92s.
335. M. Selman (1998) Hypersensitivity pneumonitis. M.I. Schwartz, T.E. King,(Eds) Interstitial Lung Disease London: BC Decker 393-422.
336. C. McSharry, S.W. Banham and G. Boyd (1985) Effect of cigarette smoking on the antibody response to inhaled antigens and the prevalence of extrinsic allergic alveolitis among pigeon breeders. Clin Allergy 15 487.
337. A.M. Patel, J.H. Ryu and C.E. Reed (2001) Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol 108(5), 661-670.
338. C. Glazer, C. Rose and D. Lynch (2002) Clinical and radiologic manifestations of hypersensitivity pneumonitis. J Thorac Imaging 17(4), 261-272.
339. P.G. Cook, I.P. Wells and C.R. McGavin (1988) The distribution of pulmonary shadowing in farmer's lung. Clin Radiol. 39(1), 21-27.
340. A. Khoor, K.O. Leslie, H.D. Tazelaar, et al. (2001) Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung). Am J Clin Pathol 115(5), 755-762.
341. R. Pham, K. Vydareny and A. Gal (2003) High-resolution computed tomography appearance of pulmonary Mycobacterium avium complex infection after exposure to hot tub: case of hot-tub lung. J Thorac Imaging 18(1), 48-52.
342. A. Coleman and T.V. Colby (1988) Histologic diagnosis of extrinsic allergic alveolitis. Am J Surg Pathol 12(7), 514-518.
343. T.V. Colby and A. Coleman (1989) Histologic differential diagnosis of extrinsic allergic alveolitis. Prog Surg Pathol 10 11-26.
344. R.M. Seal, E.J. Hapke, G.O. Thomas, et al. (1968) The pathology of the acute and chronic stages of farmer's lung. Thorax 23(5), 469-489.
345. T. Takemura, T. Akashi, Y. Ohtani, et al. (2008) Pathology of hypersensitivity pneumonitis. Curr Opin Pulm Med 14(5), 440-454.
346. R.A. Barbee, Q. Callies, H.A. Dickie and J. Rankin (1968) The long-term prognosis in farmer's lung. Am Rev Respir Dis 97(2), 223-231.
347. J. Kokkarinen, H. Tukiainen, A. Seppä and E.O. Terho (1994) Hypersensitivity pneumonitis due to native birds in a bird ringer. Chest 106(4), 1269-1271.
348. J. Kokkarinen, H. Tukiainen and E.O. Terho (1994) Mortality due to farmer's lung in Finland. Chest 106(2), 509-512.
349. J.I. Kokkarinen, H.O. Tukiainen and E.O. Terho (1992) Effect of corticosteroid treatment on the recovery of pulmonary function in farmer's lung. Am Rev Respir Dis 145(1), 3-5.
350. R. Sansores, J. Salas, R. Chapela, et al. (1990) Clubbing in hypersensitivity pneumonitis. Its prevalence and possible prognostic role. Arch Intern Med 150(9), 1849-1851.
351. R. Pérez-Padilla, M. Gaxiola, J. Salas, et al. (1996) Bronchiolitis in chronic pigeon breeder's disease. Morphologic evidence of a spectrum of small airway lesions in hypersensitivity pneumonitis induced by avian antigens. Chest 110(2), 371-377.
352. E. Brabencova, A. Tazi, M. Lorenzato, et al. (1998) Langerhans cells in Langerhans cell granulomatosis are not actively proliferating cells. Am J Pathol 152(5), 1143-1149.
353. R. Vassallo, J.H. Ryu, T.V. Colby, et al. (2000) Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 342(26), 1969-1978.
354. C.L. Willman, L. Busque, B.B. Griffith, et al. (1994) Langerhans'-cell histiocytosis (histiocytosis X)—a clonal proliferative disease. N Engl J Med 331(3), 154-160.
355. W.D. Travis, Z. Borok, J.H. Roum, et al. (1993) Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am J Surg Pathol 17(10), 971-986.
356. J.G. Parambil, J.L. Myers, M.C. Aubry and J.H. Ryu (2007) Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest 132(1), 50-57.
357. T.V. Colby and C. Lombard (1983) Histiocytosis X in the lung. Hum Pathol 14(10), 847-856.
358. S. Niku, P. Stark, D.L. Levin and P.J. Friedman (2005) Lymphangioleiomyomatosis: clinical, pathologic, and radiologic manifestations. J Thorac Imaging 20(2), 98-102.
359. J. Lacronique, C. Roth, J.P. Battesti, et al. (1982) Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases. Thorax 37(2), 104-109.
360. A.D. Moore, J.D. Godwin, N.L. Müller, et al. (1989) Pulmonary histiocytosis X: comparison of radiographic and CT findings. Radiology 172(1), 249-254.
361. E.L. Kulwiec, D.A. Lynch, S.M. Aguayo, et al. (1992) Imaging of pulmonary histiocytosis X. Radiographics 12(3), 515-526.
362. M.W. Brauner, P. Grenier, K. Tijani, et al. (1997) Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology 204(2), 497-502.
363. M. Kambouchner, F. Basset, J. Marchal, et al. (2002) Three-dimensional characterization of pathologic lesions in pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 166(11), 1419-1421.
364. T.J. McDonnell, E.C. Crouch and J.G. Gonzalez (1989) Reactive eosinophilic pleuritis. A sequela of pneumothorax in pulmonary eosinophilic granuloma. Am J Clin Pathol 91(1), 107-111.
365. F.B. Askin, B.G. McCann and C. Kuhn (1977) Reactive eosinophilic pleuritis: a lesion to be distinguished from pulmonary eosinophilic granuloma. Arch Pathol Lab Med 101 187-192.
366. A. Delobbe, J. Durieu, A. Duhamel and B. Wallaert (1996) Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Eur Respir J 9(10), 2002-2006.
367. C. Veyssier-Belot, P. Cacoub, D. Caparros-Lefebvre, et al. (1996) Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 75(3), 157-169.
368. V. Cottin, H. Nunes, P.Y. Brillet, et al. (2005) Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 26(4), 586-593.
369. M. Bisceglia, M. Cammisa, S. Suster and T.V. Colby (2003) Erdheim-Chester disease: clinical and pathologic spectrum of four cases from the Arkadi M. Rywlin slide seminars. Adv Anat Pathol 10(3), 160-171.
370. L.W. Bancroft and T.H. Berquist (1998) Erdheim-Chester disease: radiographic findings in five patients. Skeletal Radiol 27(3), 127-132.
371. V. Breuil, O. Brocq, C. Pellegrino, et al. (2002) Erdheim-Chester disease: typical radiological bone features for a rare xanthogranulomatosis. Ann Rheum Dis 61(3), 199-200.
372. R. Gottlieb and A. Chen (2002) MR findings of Erdheim-Chester disease. J Comput Assist Tomogr 26(2), 257-261.
373. J.M. Olmos, A. Canga, C. Velero and J. González-Macías (2002) Imaging of Erdheim-Chester disease. J Bone Miner Res 17(3), 381-383.
374. M. Kambouchner, T.V. Colby, C. Domenge, et al. (1997) Erdheim-Chester disease with prominent pulmonary involvement associated with eosinophilic granuloma of mandibular bone. Histopathology 30(4), 353-358.
375. A.J. Egan, L.A. Boardman, H.D. Tazelaar, et al. (1999) Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol 23(1), 17-26.
376. W.L. Rush, J.A. Andriko, F. Galateau-Salle, et al. (2000) Pulmonary pathology of Erdheim-Chester disease. Mod Pathol 13(7), 747-754.
377. K.H. Wittenberg, S.J. Swensen and J.L. Myers (2000) Pulmonary involvement with Erdheim-Chester disease: radiographic and CT findings. AJR Am J Roentgenol 174(5), 1327-1331.
378. R.D. Shamburek, H.B. Brewer Jr and B.R. Gochuico (2001) Erdheim-Chester disease: a rare multisystem histiocytic disorder associated with interstitial lung disease. Am J Med Sci 321(1), 66-75.
379. J.R. Taylor, J. Ryu, T.V. Colby and T.A. Raffin (1990) Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 323(18), 1254-1260.
380. M. Kitaichi, K. Nishimura, H. Itoh and T. Izumi (1995) Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 151(2 Pt 1), 527-533.
381. K.G. Kalassian, R. Doyle, P. Kao, et al. (1997) Lymphangioleiomyomatosis: new insights. Am J Respir Crit Care Med 155(4), 1183-1186.
382. A. Athavale, P. Chhajed, P. Singhal, et al. (1999) Pulmonary lymphangioleiomyomatosis. J Assoc Physicians India 47(6), 649-650.
383. T. Urban, R. Lazor, J. Lacronique, et al. (1999) Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P). Medicine (Baltimore) 78(5), 321-337.
384. S.C. Chu, K. Horiba, J. Usuki, et al. (1999) Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 115(4), 1041-1052.
385. L.C. Costello, T.E. Hartman and J.H. Ryu (2000) High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc 75(6), 591-594.
386. T. Sato, K. Seyama, H. Fujii, et al. (2002) Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet 47(1), 20-28.
387. J. Yu, A. Astrinidis and E.P. Henske (2001) Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. Am J Respir Crit Care Med 164(8 Pt 1), 1537-1540.
388. T. Carsillo, A. Astrinidis and E.P. Henske (2000) Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A 97(11), 6085-6090.
389. M.C. Aubry, J.L. Myers, J.H. Ryu, et al. (2000) Pulmonary lymphangioleiomyomatosis in a man. Am J Respir Crit Care Med 162(2 Pt 1), 749-752.
390. E.E. Lack, M.F. Dolan, J. Finisio, et al. (1986) Pulmonary and extrapulmonary lymphangioleiomyomatosis. Report of a case with bilateral renal angiomyolipomas, multifocal lymphangioleiomyomatosis, and a glial polyp of the endocervix. Am J Surg Pathol 10(9), 650-657.
391. R.G. Uzzo, D.M. Libby, E.D. Vaughan Jr and S.H. Levey (1994) Coexisting lymphangioleiomyomatosis and bilateral angiomyolipomas in a patient with tuberous sclerosis. J Urol 151(6), 1612-1615.
392. S.M. Bernstein, J.D. Newell Jr, D. Adamczyk, et al. (1995) How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis? Am J Respir Crit Care Med 152(6 Pt 1), 2138-2143.
393. D.E. Maziak, S. Kesten, D.C. Rappaport and J. Maurer (1996) Extrathoracic angiomyolipomas in lymphangioleiomyomatosis. Eur Respir J 9(3), 402-405.
394. H.P. Neumann, G. Schwarzkopf and E.P. Henske (1998) Renal angiomyolipomas, cysts, and cancer in tuberous sclerosis complex. Semin Pediatr Neurol 5(4), 269-275.
395. E. Tüzel, Z. Kirkali, U. Mungan, et al. (2000) Giant angiomyolipoma associated with marked pulmonary lesions suggesting lymphangioleiomyomatosis in a patient with tuberous sclerosis. Int Urol Nephrol 32(2), 219-222.
396. N.L. Müller, C. Chiles and P. Kullnig (1990) Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings. Radiology 175(2), 335-339.
397. D.C. Rappaport, G.L. Weisbrod, S.J. Herman and D.W. Chamberlain (1989) Pulmonary lymphangioleiomyomatosis: high-resolution CT findings in four cases. AJR Am J Roentgenol 152(5), 961-964.
398. P.A. Templeton, T.C. McLoud, N.L. Müller, et al. (1989) Pulmonary lymphangioleiomyomatosis: CT and pathologic findings. J Comput Assist Tomogr 13(1), 54-57.
399. R.H. Sherrier, C. Chiles and V. Roggli (1989) Pulmonary lymphangioleiomyomatosis: CT findings. AJR Am J Roentgenol 153(5), 937-940.
400. P.A. Templeton, T.C. McLoud, N.L. Müller, et al. (1989) Pulmonary lymphangioleiomyomatosis: CT and pathologic findings. J Comput Assist Tomogr 13 54-57.
401. J. Kirchner, A. Stein, K. Viel, et al. (1999) Pulmonary lymphangioleiomyomatosis: high-resolution CT findings. Eur Radiol 9(1), 49-54.
402. T. Kumasaka, K. Seyama, K. Mitani, et al. (2005) Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis. Am J Surg Pathol 29(10), 1356-1366.
403. J.R. Toro, M.H. Wei, G.M. Glenn, et al. (2008) BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet. 45(6), 321-331.
404. A. Shen, M.D. Iseman, J.A. Waldron and T.E. King (1987) Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens. Chest 91(5), 782-785.
405. A.H. Eliasson, Y.Y. Phillips and M.F. Tenholder (1989) Treatment of lymphangioleiomyomatosis. A meta-analysis. Chest 96(6), 1352-1355.
406. N.P. Ohori, S.A. Yousem, E. Sonmez-Alpan and T.V. Colby (1991) Estrogen and progesterone receptors in lymphangioleiomyomatosis, epithelioid hemangioendothelioma, and sclerosing hemangioma of the lung. Am J Clin Pathol 96(4), 529-535.
407. S. Rajjoub, M.W. Blatt and J. Ritterspach (1995) Response to treatment with progesterone in a patient with pulmonary lymphangioleiomyomatosis. W V Med J 91(7), 322-323.
408. M.H. Colley, E. Geppert and W.A. Franklin (1989) Immunohistochemical detection of steroid receptors in a case of pulmonary lymphangioleiomyomatosis. Am J Surg Pathol 13(9), 803-807.
409. F.X. McCormack (2008) Lymphangioleiomyomatosis: a clinical update. Chest 133(2), 507-516.
410. A. Boehler, R. Speich, E.W. Russi and W. Weder (1996) Lung transplantation for lymphangioleiomyomatosis. N Engl J Med 335(17), 1275-1280.
411. I. Bittmann, T.B. Dose, C. Müller, et al. (1997) Lymphangioleiomyomatosis: recurrence after single lung transplantation. Hum Pathol 28(12), 1420-1423.
412. Y. Gunji, T. Akiyoshi, T. Sato, et al. (2007) Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax. J Med Genet 44(9), 588-593.
413. B.H. Davies and E.G. Tuddenham (1976) Familial pulmonary fibrosis associated with oculocutaneous albinism and platelet function defect. A new syndrome. Q J Med 45(178), 219-232.
414. R.A. DePinho and K.L. Kaplan (1985) The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations. Medicine (Baltimore) 64(3), 192-202.
415. O. Dimson, B.A. Drolet and N.B. Esterly (1999) Hermansky-Pudlak syndrome. Pediatr Dermatol 16(6), 475-477.
416. M. Huizing and W.A. Gahl (2002) Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes. Curr Mol Med 2(5), 451-467.
417. D.M. Pierson, D. Ionescu, G. Qing, et al. (2006) Pulmonary fibrosis in Hermansky-Pudlak syndrome. A case report and review. Respiration 73(3), 382-395.
418. Y. Anikster, M. Huizing, J. White, et al. (2001) Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico. Nat Genet 28(4), 376-380.
419. C.R. Hermos, M. Huizing, M.I. Kaiser-Kupfer and W.A. Gahl (2002) Hermansky-Pudlak syndrome type 1: gene organization, novel mutations, and clinical-molecular review of non–Puerto Rican cases. Hum Mutat 20(6), 482.
420. A. Okano, A. Sato, K. Chida, et al. (1991) Pulmonary interstitial pneumonia in association with Hermansky-Pudlak syndrome. Nihon Kyobu Shikkan Gakkai Zasshi 29(12), 1596-1602.
421. N.A. Avila, M. Brantly, A. Premkumar, et al. (2002) Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies. AJR Am J Roentgenol 179(4), 887-892.
422. Y. Nakatani, N. Nakamura, J. Sano, et al. (2000) Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes. Virchows Arch 437(3), 304-313.
423. W.A. Gahl, M. Brantly, J. Troendle, et al. (2002) Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome. Mol Genet Metab 76(3), 234-242.
424. M.C. Sosman, G.D. Dodd, W.D. Jones and G.U. Pillmore (1957) The familial occurrence of pulmonary alveolar microlithiasis. Am J Roentgenol Radium Ther Nucl Med 77 947-952.
425. F.J. Fuleihan, R.T. Abboud, J.P. Balikian and C.K. Nucho (1969) Pulmonary alveolar microlithiasis: lung function in five cases. Thorax 24 84-90.
426. U.B. Prakash, S.S. Barham, E.C. Rosenow 3rd, et al. (1983) Pulmonary alveolar microlithiasis. A review including ultrastructural and pulmonary function studies. Mayo Clin Proc 58(5), 290-300.
427. M. Edelweiss, L.J. Medeiros, S. Suster and C.A. Moran (2007) Lymph node involvement by Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical study of 20 cases. Hum Pathol 38(10), 1463-1469.
428. G. Castellana, M. Gentile, R. Castellana, et al. (2002) Pulmonary alveolar microlithiasis: clinical features, evolution of the phenotype, and review of the literature. Am J Med Genet 111(2), 220-224.
429. A. Senyiğit, A. Yaramiş, F. Gürkan, et al. (2001) Pulmonary alveolar microlithiasis: a rare familial inheritance with report of six cases in a family. Contribution of six new cases to the number of case reports in Turkey. Respiration 68(2), 204-209.
430. I.S. Huqun, H,. Miyazawa, K. Ishii, et al. (2007) Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med 175(3), 263-268.
431. K. Pant, A. Shah, R.K. Mathur, et al. (1990) Pulmonary alveolar microlithiasis with pleural calcification and nephrolithiasis. Chest 98 245-246.
432. Y. Chang, P.C. Yang, K.T. Luh, et al. (1999) High-resolution computed tomography of pulmonary alveolar microlithiasis. J Formos Med Assoc 98(6), 440-443.
433. B.C. Trapnell, J.A. Whitsett and K. Nakata (2003) Pulmonary alveolar proteinosis. N Engl J Med 349(26), 2527-2539.
434. T. Kitamura, N. Tanaka, J. Watanabe, et al. (1999) Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 190(6), 875-880.
435. Y. Inoue, B.C. Trapnell, R. Tazawa, et al. (2008) Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 177(7), 752-762.
436. G. Singh, S.L. Katyal, C.W. Bedrossian and R.M. Rogers (1983) Pulmonary alveolar proteinosis. Staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it. Chest 83 82-86.
437. R.R. Miller, A.M. Churg, M. Hutcheon and S. Lom (1984) Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 130 312-315.
438. C.W. Bedrossian, M.A. Luna, R.H. Conklin and W.C. Miller (1980) Alveolar proteinosis as a consequence of immunosuppression. A hypothesis based on clinical and pathologic observations. Hum Pathol 11(suppl 5), 527-535.
439. Y. Wang, J. Xia and Q.W. Wang (1988) Clinical report on 62 cases of acute dimethyl sulfate intoxication. Am J Ind Med 13(4), 455-462.
440. J. Seymour and J. Presneill (2002) Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 166(2), 215-235.
441. P. Shah, D. Hansell, P.R. Lawson, et al. (2000) Pulmonary alveolar proteinosis: clinical aspects and current concepts in pathogenesis. Thorax 55 67-77.
442. J. Davidson and W. MacLeod (1969) Pulmonary alveolar proteinosis. Br J Dis Chest 63 13-16.
443. D.A. Lynch, J.D. Godwin, S. Safrin, et al. (2005) High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 172(4), 488-493.
444. W. Claypool, R. Roger and G. Matuschak (1984) Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis). Chest 85 550-558.
445. M.E. Wylam, R. Ten, U.B. Prakash, et al. (2006) Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Eur Respir J 27(3), 585-593.
446. R. Tazawa, E. Hamano, T. Arai, et al. (2005) Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 171(10), 1142-1149.
447. E. Heitzman (1984) The Lung: Radiologic-Pathologic Correlations 2nd ed St. Louis: Mosby
448. P.L. Munk, N.L. Müller, R.R. Miller and D.N. Ostrow (1988) Pulmonary lymphangitic carcinomatosis: CT and pathologic findings. Radiology 166 705-709.
449. M. Janower and J. Blennerhassett (1971) Lymphangitic spread of metastatic cancer to the lung: a radiologic-pathologic classification. Radiology 101 267-273.
450. M.G. Stein, J. Mayo, N. Müller, et al. (1987) Pulmonary lymphangitic spread of carcinoma: appearance on CT scans. Radiology 162 371-375.
451. H.S. Goldsmith, H.D. Bailey, E.L. Callahan and E.J. Beattie Jr (1967) Pulmonary lymphangitic metastases from breast carcinoma. Arch Surg 94 483-488.
452. C.P. Wall, E.A. Gaensler, C.B. Carrington and J.A. Hayes (1981) Comparison of transbronchial and open biopsies in chronic infiltrative lung disease. Am Rev Respir Dis 123 280-285.
453. S.K. Frankel, C.D. Cool, D.A. Lynch and K.K. Brown (2004) Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 126(6), 2007-2013.
454. C.D. Becker, J. Gil and M.L. Padilla (2008) Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity? Mod Pathol 21(6), 784-787.
455. S. Shiota, K. Shimizu, M. Suzuki, et al. (1999) Seven cases of marked pulmonary fibrosis in the upper lobe. Nihon Kokyuki Gakkai Zasshi 37(2), 87-96.
456. H. Kamoi, T. Okamoto, N. Yoshimura, et al. (2002) A case of interstitial pneumonia in the upper lung field histologically diagnosed as nonspecific interstitial pneumonia complicated by bilateral pneumothorax. Nihon Kokyuki Gakkai Zasshi 40(12), 936-940.
457. P. Krakówka, A. Meleniewska-Maciszewska, B. Lesiak, et al. (1985) Pulmonary fibrosis of the upper lobe resembling tuberculosis in patients without ankylosing spondylitis. Pneumonol Pol 53(1), 39-47.